Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.

Lynch syndrome (LS) leads to an increased risk of early-onset colorectal and other types of cancer and is caused by germline mutations in DNA mismatch repair (MMR) genes. Loss of MMR function results in a mutator phenotype that likely underlies its role in tumorigenesis. However, loss of MMR also re...

Full description

Bibliographic Details
Main Authors: Jessica P Hollenbach, Alissa M Resch, Dasaradhi Palakodeti, Brenton R Graveley, Christopher D Heinen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3128615?pdf=render
_version_ 1819162787026305024
author Jessica P Hollenbach
Alissa M Resch
Dasaradhi Palakodeti
Brenton R Graveley
Christopher D Heinen
author_facet Jessica P Hollenbach
Alissa M Resch
Dasaradhi Palakodeti
Brenton R Graveley
Christopher D Heinen
author_sort Jessica P Hollenbach
collection DOAJ
description Lynch syndrome (LS) leads to an increased risk of early-onset colorectal and other types of cancer and is caused by germline mutations in DNA mismatch repair (MMR) genes. Loss of MMR function results in a mutator phenotype that likely underlies its role in tumorigenesis. However, loss of MMR also results in the elimination of a DNA damage-induced checkpoint/apoptosis activation barrier that may allow damaged cells to grow unchecked. A fundamental question is whether loss of MMR provides pre-cancerous stem cells an immediate selective advantage in addition to establishing a mutator phenotype. To test this hypothesis in an in vivo system, we utilized the planarian Schmidtea mediterranea which contains a significant population of identifiable adult stem cells. We identified a planarian homolog of human MSH2, a MMR gene which is mutated in 38% of LS cases. The planarian Smed-msh2 is expressed in stem cells and some progeny. We depleted Smed-msh2 mRNA levels by RNA-interference and found a striking survival advantage in these animals treated with a cytotoxic DNA alkylating agent compared to control animals. We demonstrated that this tolerance to DNA damage is due to the survival of mitotically active, MMR-deficient stem cells. Our results suggest that loss of MMR provides an in vivo survival advantage to the stem cell population in the presence of DNA damage that may have implications for tumorigenesis.
first_indexed 2024-12-22T17:33:47Z
format Article
id doaj.art-5a921c0c0f5042129ced3804acaa0ec6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T17:33:47Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5a921c0c0f5042129ced3804acaa0ec62022-12-21T18:18:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0167e2180810.1371/journal.pone.0021808Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.Jessica P HollenbachAlissa M ReschDasaradhi PalakodetiBrenton R GraveleyChristopher D HeinenLynch syndrome (LS) leads to an increased risk of early-onset colorectal and other types of cancer and is caused by germline mutations in DNA mismatch repair (MMR) genes. Loss of MMR function results in a mutator phenotype that likely underlies its role in tumorigenesis. However, loss of MMR also results in the elimination of a DNA damage-induced checkpoint/apoptosis activation barrier that may allow damaged cells to grow unchecked. A fundamental question is whether loss of MMR provides pre-cancerous stem cells an immediate selective advantage in addition to establishing a mutator phenotype. To test this hypothesis in an in vivo system, we utilized the planarian Schmidtea mediterranea which contains a significant population of identifiable adult stem cells. We identified a planarian homolog of human MSH2, a MMR gene which is mutated in 38% of LS cases. The planarian Smed-msh2 is expressed in stem cells and some progeny. We depleted Smed-msh2 mRNA levels by RNA-interference and found a striking survival advantage in these animals treated with a cytotoxic DNA alkylating agent compared to control animals. We demonstrated that this tolerance to DNA damage is due to the survival of mitotically active, MMR-deficient stem cells. Our results suggest that loss of MMR provides an in vivo survival advantage to the stem cell population in the presence of DNA damage that may have implications for tumorigenesis.http://europepmc.org/articles/PMC3128615?pdf=render
spellingShingle Jessica P Hollenbach
Alissa M Resch
Dasaradhi Palakodeti
Brenton R Graveley
Christopher D Heinen
Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
PLoS ONE
title Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
title_full Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
title_fullStr Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
title_full_unstemmed Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
title_short Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.
title_sort loss of dna mismatch repair imparts a selective advantage in planarian adult stem cells
url http://europepmc.org/articles/PMC3128615?pdf=render
work_keys_str_mv AT jessicaphollenbach lossofdnamismatchrepairimpartsaselectiveadvantageinplanarianadultstemcells
AT alissamresch lossofdnamismatchrepairimpartsaselectiveadvantageinplanarianadultstemcells
AT dasaradhipalakodeti lossofdnamismatchrepairimpartsaselectiveadvantageinplanarianadultstemcells
AT brentonrgraveley lossofdnamismatchrepairimpartsaselectiveadvantageinplanarianadultstemcells
AT christopherdheinen lossofdnamismatchrepairimpartsaselectiveadvantageinplanarianadultstemcells